James J. Dignam to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications James J. Dignam has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
0.162
-
Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx. Cancer. 2019 03 01; 125(5):704-711.
Score: 0.162
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.